Antitumor antibiotic which inhibits topoisomerase II. Induces single-strand scission in DNA in the presence of reducing agents.
Product Specification
Alternative Name: | Lambdamycin |
|
Formula: | C32H32O14 |
|
MW: | 640.6 |
|
Source: | Isolated from Streptomyces chartreusis. |
|
CAS: | 6377-18-0 |
|
MI: | 14: 2045 |
|
RTECS: | FL7350000 |
|
Purity: | ≥98% (HPLC) |
|
Identity: | Determined by 1H-NMR. |
|
Appearance: | Yellow solid. |
|
Solubility: | Soluble in acetone; insoluble in water. |
|
Shipping: | Ambient |
|
Short Term Storage: | +4°C |
|
Long Term Storage: | +4°C |
|
Use/Stability: | Stable for at least 1 year after receipt when stored at +4°C. |
|
Handling: | After reconstitution protect from light at -20°C. |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Chartreusin, elsamicin A and related anti-cancer antibiotics: J. Portugal; Curr. Med. Chem. Anticancer Agents
3, 411 (2003), Review,
Abstract;
Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II: A. Lorico & B.H. Long; Eur. J. Cancer
14, 1985 (1993),
Abstract;
Chartreusin, a glycosidic antitumour antibiotic from Streptomyces: J.A. Beisler; Prog. Med. Chem.
19, 247 (1982), (Review),
Abstract;
Chartreusin, a New Antibiotic Produced by Streptomyces chartreusis, a New Species: B. E. Leach, et al.; J. Am. Chem. Soc. 75, 4011 (1953),